Premium
Penn Medicine Head and Neck Cancer Service Line COVID ‐19 management guidelines
Author(s) -
Weinstein Gregory S.,
Cohen Roger,
Lin Alexander,
O'Malley Bert W.,
Lukens John,
SwisherMcClure Samuel,
Shanti Rabie M.,
Newman Jason G.,
Parhar Harman S.,
Tasche Kendall,
Brody Robert M.,
Chalian Ara,
Cannady Steven,
Palmer James N.,
Adappa Nithin D.,
Kohanski Michael A.,
Bauml Joshua,
Aggarwal Charu,
Montone Kathleen,
Livolsi Virginia,
Baloch Zubair W.,
Jalaly Jalal B.,
Cooper Kumarasen,
Rajasekaran Karthik,
Loevner Laurie,
Rassekh Christopher
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26318
Subject(s) - pandemic , medicine , head and neck cancer , covid-19 , head and neck , health care , cancer , surgery , infectious disease (medical specialty) , political science , disease , law
The COVID‐19 pandemic caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits. Methods Creation of consensus document. Results The process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system. Conclusions These guidelines support an ethical approach for the management of head and neck cancers during the COVID‐19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.